# IV Hydrogen Nanobubbles for Cardiac Function and QoL

> **NCT07085637** · NA · COMPLETED · sponsor: **Indonesia Molecule Institute** · enrollment: 52 (actual)

## Conditions studied

- Cardiovascular Diseases
- Hypertension
- Blood Pressure

## Interventions

- **OTHER:** intravenous infusion of hydrogen nanobubbles (HNB) administered twice weekly over a 5-week period

## Key facts

- **NCT ID:** NCT07085637
- **Lead sponsor:** Indonesia Molecule Institute
- **Sponsor class:** NETWORK
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-19
- **Primary completion:** 2022-11-04
- **Final completion:** 2022-11-04
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2025-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07085637

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07085637, "IV Hydrogen Nanobubbles for Cardiac Function and QoL". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT07085637. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*